Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression

Autor: Yonglong Zhang, Malcolm A. Finkelman, Ronald J. Bosch, Alan L. Landay, Daniela Moisi, Sara Gianella, Jesper Eugen-Olsen, Martin Hoenigl, Jochen Reiser, Carlee Moser, Michael M. Lederman, Amy Kantor, Nicholas T. Funderburg
Rok vydání: 2019
Předmět:
0301 basic medicine
Oncology
Male
Adult Clinical Trials Group NWCS 411 study team
HIV Infections
Medical and Health Sciences
Pathogenesis
0302 clinical medicine
Interquartile range
Receptors
2.1 Biological and endogenous factors
030212 general & internal medicine
Aetiology
Articles and Commentaries
biology
Viral Load
Middle Aged
Biological Sciences
Infectious Diseases
Urokinase Plasminogen Activator
HIV/AIDS
Female
medicine.symptom
Infection
Lipopolysaccharide binding protein
Microbiology (medical)
Adult
medicine.medical_specialty
viral suppression
030106 microbiology
Inflammation
Microbiology
Receptors
Urokinase Plasminogen Activator

suPAR
03 medical and health sciences
Young Adult
Acquired immunodeficiency syndrome (AIDS)
Clinical Research
Internal medicine
non-AIDS mortality
medicine
Humans
Aged
lipopolysaccharide binding protein
business.industry
Odds ratio
medicine.disease
Clinical trial
beta-D-glucan
Good Health and Well Being
SuPAR
biology.protein
business
Biomarkers
Zdroj: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 69, iss 4
Popis: Author(s): Hoenigl, Martin; Moser, Carlee B; Funderburg, Nicholas; Bosch, Ronald; Kantor, Amy; Zhang, Yonglong; Eugen-Olsen, Jesper; Finkelman, Malcolm; Reiser, Jochen; Landay, Alan; Moisi, Daniela; Lederman, Michael M; Gianella, Sara; Adult Clinical Trials Group NWCS 411 study team | Abstract: BackgroundDespite effective antiretroviral therapy (ART), human immunodeficiency virus (HIV) infection remains associated with higher morbidity and mortality, driven, in part, by increased inflammation. Our objective was to identify associations between levels of plasma biomarkers of chronic inflammation, microbial translocation, and monocyte activation, with occurrence of non-AIDS events.MethodsParticipants (141 cases, 310 matched controls) were selected from a longitudinal observational trial; all were virally suppressed on ART at year 1 and thereafter. Soluble urokinase plasminogen activator receptor (suPAR), lipopolysaccharide binding protein (LBP), beta-D-glucan (BDG), intestinal fatty-acid binding protein, oxidized low-density lipoproteins, and soluble CD163 were measured pre-ART, after 1-year of ART, and pre-event. At each time point, conditional logistic regression analysis assessed associations of the biomarkers with events and adjusted for relevant covariates to calculate odds ratios (ORs) according to 1 interquartile range (IQR) difference.ResultsAt all time points, higher levels of suPAR were associated with increased risk of non-AIDS events (OR per 1 IQR was 1.7 before ART-initiation, OR per 1 IQR was 2.0 after 1 year of suppressive ART, and OR 2.1 pre-event). Higher levels of BDG and LBP at year 1 and pre-event (but not at baseline) were associated with increased risk of non-AIDS events. No associations were observed for other biomarkers.ConclusionsElevated levels of suPAR were strongly, consistently, and independently predictive of non-AIDS events at every measured time point. Interventions that target the suPAR pathway should be investigated to explore its role in the pathogenesis of non-AIDS-related outcomes in HIV infection.
Databáze: OpenAIRE